Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2022-05-09 Earnings Release
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Ricavi 1Q2022
Earnings Release Classification · 99% confidence The document is titled 'COMUNICATO STAMPA' (Press Release) and its subject ('Oggetto') is 'Ricavi 1Q2022' (1Q2022 Revenues). It details the consolidated revenue for the first quarter of 2022 (€21.3 million, +12.1% YoY) and provides commentary from the CEO. This structure—a brief announcement highlighting key financial figures for a recent period (Q1)—is characteristic of an Earnings Release (ER). Although it mentions 'Vedi allegato' (See attachment), the core content provided is the summary of the results, not just an announcement of the report's publication. Since it provides the key results summary, it fits ER better than RPA, which is usually just a notice that a full report is available. Q1 2022
2022-05-09 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and explicitly states the subject ('Oggetto') as 'Acquisto azioni proprie' (Purchase of own shares). It details the number of shares bought, the average price, and the total consideration for the period May 2 to May 6, 2022. This activity falls directly under the definition of a company reporting transactions involving its own shares, which corresponds to the 'Transaction in Own Shares' category.
2022-05-06 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and details the number of shares the company purchased during the period from April 25 to April 29, 2022. The 'Oggetto' (Subject) field explicitly states 'Acquisto azioni proprie' (Purchase of own shares). This activity directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs.
2022-04-29 Italian
CDA - Approvazione Progetto di Bilancio al 31.12.2021
Earnings Release Classification · 95% confidence The document is a press release dated April 14, 2022, announcing the approval of the draft annual and consolidated financial statements as of December 31, 2021, by the Board of Directors. It contains detailed financial highlights (Revenues, EBITDA, Net Income) for the year 2021 and includes tables summarizing the Consolidated Income Statement and Parent Company Financial Statements for the year ended 12/31/2021 compared to 12/31/2020. This content strongly indicates the release of annual financial results. Since it is a press release announcing the results (not the full statutory 10-K filing itself, which is typically much longer and filed with the SEC/CONSOB), it aligns best with the Earnings Release (ER) category, which covers the initial announcement of periodical financial results (key highlights). Although it contains more detail than a typical ER, the structure as a 'COMUNICATO STAMPA' (Press Release) approving the 'Progetto di Bilancio' (Draft Financial Statements) points to the initial public disclosure of annual results. FY 2021
2022-04-14 Italian
Fatturato consolidato preliminare 2021
Earnings Release Classification · 98% confidence The document is a regulatory announcement (Informazione Regolamentata) from SVAS BIOSANA dated February 14, 2022. The subject ('Oggetto') is 'Fatturato consolidato preliminare 2021' (Preliminary consolidated turnover 2021). The text explicitly states the preliminary 2021 revenue figures and mentions that the definitive results will be examined later. This is a release of key, preliminary financial highlights for a period, which aligns perfectly with the definition of an Earnings Release (ER). Although it mentions 'Vedi allegato' (See attachment), the core content provided is the summary of the results, making it the release itself rather than just an announcement of the release (RPA). FY 2021
2022-02-14 Italian
Comunicato
Regulatory Filings Classification · 98% confidence The document is identified as an 'Informazione Regolamentata' (Regulated Information) from Euronext Growth Milan, dated February 3, 2022, with a dissemination date of February 4, 2022. The subject is a 'Comunicato Stampa' (Press Release) announcing the award of contracts worth EUR 8.92 million. This type of announcement, which communicates material, non-financial business updates (like contract wins) outside of scheduled earnings reports, typically falls under general regulatory announcements. Since it is not a formal financial report (10-K, IR), an earnings release (ER), or a specific corporate action like a dividend (DIV) or share transaction (POS), the most appropriate classification is the general regulatory filing category, RNS (Regulatory Filings), as it serves as a broad announcement of material information.
2022-02-04 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.